Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway.

Ahn KS, Sethi G, Shishodia S, Sung B, Arbiser JL, Aggarwal BB. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway. Mol Cancer Res. 2006 Sep; 4(9):621-33.

View in: PubMed

subject areas

Animals
Apoptosis
Biphenyl Compounds
Carrier Proteins
Cyclin D1
Cyclooxygenase 2
Dose-Response Relationship, Drug
Drug Synergism
Genes, myc
Humans
I-kappa B Proteins
Lignans
Matrix Metalloproteinase 9
Membrane Glycoproteins
Membrane Proteins
Mice
Molecular Structure
NF-kappa B
Osteoclasts
Osteogenesis
Phosphorylation
Promoter Regions, Genetic
RANK Ligand
Receptor Activator of Nuclear Factor-kappa B
Synaptotagmin I
Tumor Necrosis Factor-alpha
Vascular Endothelial Growth Factor A

authors with profiles

Shishir Shishodia

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support